FDA Creates Import Alert For Ayurvedic Supplements Linked To High Lead, Mercury Levels
This article was originally published in The Tan Sheet
FDA creates an alert identifying only products made by Shree Baidyanath Ayurved Bhawan Pvt. at three manufacturing sites. The agency in January also updates around 75 alerts to seize imports of kratom-containing supplements.
You may also be interested in...
US Ninth Circuit affirms a district court’s summary judgment in favor of Target and manufacturer of Up & Up brand biotin supplement it sells. Indian manufacturer targeted in putative class-action in New York prompted FDA’s 2016 creation of import alert category for Ayurvedic supplements.
The first budget proposal by President Trump suggests research by FDA's National Center for Toxicological Research on food- and nutritional supplement-related issues will be curtailed as part of a $3m cut to the center's appropriation.
“There is no bright-line requirement that a company possess randomized, controlled clinical studies before making so-called ‘health benefit’ claims for dietary supplements,” CRN states in petition. FTC, however, says it “makes no bright-line distinctions between categories of health-related products or claims.”